Novel tigecycline resistance mechanisms in Acinetobacter baumannii mediated by mutations in adeS, rpoB and rrf

Novel tigecycline resistance mechanisms in Acinetobacter baumannii mediated by mutations in adeS, rpoB and rrf

Acinetobacter baumannii is an important pathogen in hospital acquired infections. Although tigecycline currently remains a potent antibiotic for treating infections caused by multidrug resistant A. baumannii (MDRAB) strains, reports of tigecycline resistant isolates have substantially increased. The...

Full description

Bibliographic Details
Main Authors: Xiaoting Hua, Jintao He, Jingfen Wang, Linghong Zhang, Linyue Zhang, Qingye Xu, Keren Shi, Sebastian Leptihn, Yue Shi, Xiaoting Fu, Pengfei Zhu, Paul G. Higgins, Yunsong Yu
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Emerging Microbes and Infections
Subjects:
Multidrug-resistant A. baumannii
tigecycline resistance
adeS
rpoB
rrf
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2021.1948804

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2021.1948804

Similar Items